Quantitative measurement of handwriting in the assessment of drug-induced parkinsonism

Human Movement Science

Volumn 25, Issue 4-5, 2006, Pages 510-522

  Caligiuri, Michael P ^a   Teulings, Hans Leo ^b   Filoteo, J Vincent ^a   Song, David ^c   Lohr, James B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NeuroScript LLC   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Motor control; Neuroleptic; Parkinsonism; Psychopharmacology; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

AGE DISTRIBUTION; ARTICLE; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DRUG INDUCED DISEASE; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HANDWRITING; HUMAN; KINEMATICS; MALE; MOTOR PERFORMANCE; PARKINSON DISEASE; PARKINSONISM; PSYCHOMETRY; QUANTITATIVE ANALYSIS; SCHIZOPHRENIA; VELOCITY;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; COMPUTER GRAPHICS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HANDWRITING; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PARKINSONIAN DISORDERS; REACTION TIME; SCHIZOPHRENIA; SIGNAL PROCESSING, COMPUTER-ASSISTED;

EID: 33749683332     PISSN: 01679457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humov.2006.02.004     Document Type: Article

References (34)

1. Adler C.H., Teulings H.L., and Stelmach G.E. Handwriting abnormalities in Parkinson's disease and response to treatments. Movement Disorders 12 Suppl. 1 (1997) 47
2. American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC.
3. Becker G., Muller A., Braune S., et al. Early diagnosis of Parkinson's disease. Journal of Neurology 249 Suppl. 3 (2002) 40-48
4. Berardelli A., Rothwell J.C., Thompson P.D., and Hallett M. Pathophysiology of bradykinesia in Parkinson's disease. Brain 124 (2001) 2131-2146
5. Bullock D., Grossberg S., and Mannes C. A neural network model for cursive script production. Biological Cybernetics 70 (1993) 49-90
6. Caligiuri M.P. Instrumental measurement of tardive dyskinesia. In: Yassa R., and Jeste D.V. (Eds). Neuroleptic-induced movement disorders: A comprehensive survey (1997), Cambridge University Press, Cambridge 241-256
7. Caligiuri M.P., Jeste D.V., and Lacro J.P. Antipsychotic-induced movement disorders in the elderly: Epidemiology and treatment recommendations. Drugs and Aging 17 (2000) 363-384
8. Caligiuri M.P., and Lohr J.B. A disturbance in the control of muscle force in neuroleptic-naive schizophrenic patients. Biological Psychiatry 35 (1994) 104-111
9. Caligiuri M.P., Lohr J.B., and Ruck R.K. Scaling of movement velocity: A measure of neuromotor retardation in individuals with psychopathology. Psychophysiology 35 (1998) 431-437
10. Contreras-Vidal J.L., and Stelmach G.E. A neural model of basal ganglia-thalamocortical relations in normal and parkinsonian movement. Biological Cybernetics 73 (1995) 467-478
11. Cortese L., Caligiuri M.P., Malla A.K., Manchanda R., Takhar J., and Haricharan R. Relationship of neuromotor disturbances to psychosis symptoms in first-episode neuroleptic-naive schizophrenia patients. Schizophrenia Research 75 (2005) 65-75
12. Fahn S., and Elton R.L. Unified Parkinson's disease rating scale. In: Fahn S., Marsden C.D., Calne D., and Goldstein M. (Eds). Recent developments in Parkinson's disease (1987), Macmillan Health Care Information, Florham Park, NJ 153-164
13. Gerken A., Wetzel H., and Benkert O. Extrapyramidal symptoms and their relationship to clinical efficacy under perphenazine treatment. A controlled prospective handwriting-test study in 22 acutely ill schizophrenic patients. Pharmacopsychology 24 (1991) 132-137
14. Haase H.J. Extrapyramidal modification of fine movements: a "conditio sine qua non" of the fundamental therapeutic action of neuroleptic drugs. Review of Canadian Biology 20 (1961) 425-449
15. Haase H.J. The purely neuroleptic effects and its relation to the "neuroleptic threshold". Acta Psychiatrica Belgica 78 (1978) 19-36
16. Hollerbach J.M. An oscillation theory of handwriting. Biological Cybernetics 39 (1981) 139-156
17. Kuenstler U., Hohdorf K., Regenthal R., Seese A., and Gertz H.J. Diminution of hand writing area and D2-dopamine receptor occupancy blockade: Results from treatment with typical and atypical neuroleptics. Nervenarzt 71 (2000) 373-379
18. Kuenstler U., Juhnhold U., Knapp W.H., and Gertz H.H. Positive correlation between reduction in handwriting area and D2 dopamine receptor occupancy during treatment with neuroleptic drugs. Psychiatric Research 90 (1999) 31-39
19. Leucht S., Wahlbeck K., Hamann J., and Kissling W. New generation antipsychotics versus low-potency conventional antipsychotics: A systematic review and meta-analysis. Lancet 361 (2003) 1581-1589
20. Liu X., Carroll C.B., Wang S.-Y., Zajicek J., and Bain P.G. Quantifying drug-induced dyskinesias in the arms using digitized spiral-drawing tasks. Journal of Neuroscience Methods 144 (2005) 47-52
21. Mahant P.R., and Stacy M.A. Movement disorders and normal aging. Neurologic Clinics 19 (2001) 553-563
22. Margolin D.I., and Wing A.M. Agraphia and micrographia: Clinical manifestations of motor programming and performance disorders. Acta Psychologica 54 (1983) 263-283
23. Ondo W.G., Wang A., Thomas M., and Vuong K.D. Evaluating factors that can influence spirography ratings in patients with essential tremor. Parkinsonism and Related Disorders 11 (2005) 45-48
24. Pfann K.D., Buchman A.S., Comella C.L., and Corcos D.M. Control of movement distance in Parkinson's disease. Movement Disorders 16 (2001) 1048-1065
25. Potvin A.R., Syndulko K., Tourtellote W.W., Lemmon J.A., and Potvin J.H. Human neurologic function and the aging process. The American Journal of Geriatric Psychiatry 29 (1980) 1-9
26. Robichaud J.A., Pfann K.D., Comella C.L., and Corcos D.M. Effect of medication on EMG patterns in individuals with Parkinson's disease. Movement Disorders 17 (2002) 950-960
27. Simpson G.M., and Angus J.W. A rating scale for extrapyramidal side effects. Acta Psychiatrica Scandinavica Supplementum 212 (1970) 11-19
28. Teulings H.L., Contreras-Vidal J.L., Stelmach G.E., and Adler C.H. Coordination of fingers, wrist, and arm in Parkinsonian handwriting. Experimental Neurology 146 (1997) 159-170
29. Teulings H.L., and Stelmach G.E. Force amplitude and force duration in parkinsonian handwriting. In: Requin J., and Stelmach G.E. (Eds). Tutorials in motor neurosciences (1991), Kluwer, Dordrecht 149-160
30. Van Gemmert A.W.A., Adler C.H., and Stelmach G.E. Parkinson's disease patients undershoot target size in handwriting and similar tasks. Journal of Neurology, Neurosurgery, and Psychiatry 74 (2003) 1502-1508
31. Van Gemmert, A. W. A., Adler, C. H., Teulings, H. L., & Stelmach, G. E. (2004). Differential effects on handwriting and spiral drawing in de novo and levodopa treated Parkinson's disease patients. Neuroscience Abstracts no. 1011.14.
32. Van Gemmert A.W.A., Teulings H.L., Contreras-Vidal J.L., and Stelmach G.E. Parkinson's disease and the control of size and speed of handwriting. Neuropsychologia 37 (1999) 685-694
33. Van Gemmert A.W.A., Teulings H.L., and Stelmach G.E. Parkinsonian patients reduce their stroke size with increased processing demands. Brain and Cognition 47 (2001) 504-512
34. Wang S., Bain P.G., Aziz T.Z., and Liu X. The direction of oscillation in spiral drawings can be used to differentiate distal and proximal arm tremor. Neuroscience Letters 384 (2005) 188-192